This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Clorox Management Discusses Q4 2012 Results - Earnings Call Transcript

The Clorox (CLX)

Q4 2012 Earnings Call

August 02, 2012 1:30 pm ET


Steve Austenfeld - Former Vice President of Investor Relations

Stephen M. Robb - Chief Financial Officer and Senior Vice President

Donald R. Knauss - Chairman, Chief Executive Officer and Chairman of Executive Committee

Lawrence S. Peiros - Chief Operating Officer and Executive Vice President


Alice Beebe Longley - The Buckingham Research Group Incorporated

Linda Bolton-Weiser - Caris & Company, Inc., Research Division

Ali Dibadj - Sanford C. Bernstein & Co., LLC., Research Division

John A. Faucher - JP Morgan Chase & Co, Research Division

Wendy Nicholson - Citigroup Inc, Research Division

Javier Escalante - Consumer Edge Research, LLC

Timothy A. Conder - Wells Fargo Securities, LLC, Research Division

Leigh Ferst - Wellington Shields & Co., LLC, Research Division

Dara W. Mohsenian - Morgan Stanley, Research Division

William Schmitz - Deutsche Bank AG, Research Division

Constance Marie Maneaty - BMO Capital Markets U.S.

Christopher Ferrara - BofA Merrill Lynch, Research Division

Lauren R. Lieberman - Barclays Capital, Research Division

Ian Gordon

Jason Gere - RBC Capital Markets, LLC, Research Division



Thank you for standing by. Good day, ladies and gentlemen, and welcome to The Clorox Company's Fourth Quarter Fiscal Year 2012 Earnings Release Conference Call. [Operator Instructions] As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference, Mr. Steve Austenfeld, Vice President of Investor Relations for The Clorox Company. Mr. Austenfeld, you may begin the conference.

Steve Austenfeld

Great. Thank you. Welcome, everyone, and thank you for joining Clorox's fourth quarter conference call. On the call with me today are Don Knauss, Clorox's Chairman and CEO; Larry Peiros, our Executive Vice President and Chief Operating Officer; and Steve Robb, our Chief Financial Officer. We're broadcasting this call via the Internet, and a replay of the call will be available for 7 days at our website,

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs